Skip to content

Evaluation of the Predictive Value of Subcutaneous Fat Deposition on Opportunistic CT for Renal Ischemia in Patients With Inflammatory Bowel Disease

Evaluation of the Predictive Value of Subcutaneous Fat Deposition on Opportunistic CT for Renal Ischemia in Patients With Inflammatory Bowel Disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129517
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-08-05
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Ischemia Complicated With Inflammatory Bowel Disease

Interventions

IBD with rental ischemia:None
IBD without rental ischemia:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Based on the European Crohn's and Colitis Organization (ECCO) or the current consensus on the diagnosis and treatment of IBD in China, combined with clinical, endoscopic, imaging, and histopathological results, patients diagnosed with IBD (CD or UC) are clearly identified; 2. The ischemic group needs to be diagnosed with renal cortical ischemia or renal infarction through abdominal enhanced CT during this hospitalization/onset period (imaging manifestations include wedge-shaped or segmental low enhancement/enhancement defect areas of renal parenchyma); 3. Prior to the diagnosis of ischemia (ischemia group) or matching node (control group), within a short period of time (such as within one month), have complete and qualified abdominal plain CT data, and the scanning range fully covers the third lumbar spine (L3) plane, for the extraction of opportunistic body components; 4. The obtained abdominal plain scan CT data should have a uniform and constant scanning tube voltage of 120 kVp (conventional abdominal standard tube voltage), and the scanning layer thickness reconstructed at L3 level should be <= 5.0 mm to minimize the interference of partial volume effect on pixel segmentation of muscle/fat junction area.

Exclusion criteria

Exclusion criteria: 1. Patients with other definite high-risk embolic diseases or history (e.g., cardiogenic embolism due to atrial fibrillation, known severe hereditary thrombophilia, aortic dissection, etc.); 2. Patients with severe primary renal disease (e.g., end-stage renal disease, severe diabetic nephropathy or hypertensive nephropathy requiring dialysis) that may cause abnormal baseline renal perfusion structure; 3. Patients with active malignant tumors (tumor cachexia may severely interfere with the true metabolic status of body composition); 4. Patients with severe artifacts at the abdominal CT L3 level (e.g., artifacts from metal implants), massive ascites, or missing images, which preclude accurate segmentation and extraction of skeletal muscle area, subcutaneous fat area, and visceral fat area (SMA, SFA, VFA).

Design outcomes

Primary

MeasureTime frame
Renal ischemia;

Secondary

MeasureTime frame
Subcutaneous Fat Area (SFA);Visceral Fat Area (VFA);Skeletal Muscle Area (SMA);

Countries

China

Contacts

Public ContactDu Mingshan

The First Affiliated Hospital of Army Medical University

191173800@qq.com+86 23 68766520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026